-
Signature
-
/s/ Jeffrey Meckler
-
Issuer symbol
-
INDP
-
Transactions as of
-
11 Feb 2026
-
Net transactions value
-
$0
-
Form type
-
4
-
Filing time
-
13 Feb 2026, 16:15:18 UTC
Reporting Owners (1)
| Name |
Relationship |
Address |
Signature |
Signature date |
CIK |
| Meckler Jeffrey A |
Co-Chief Executive Officer, Director |
C/O INDAPTUS THERAPEUTICS, INC, 3 COLUMBUS CIRCLE, 15TH FLOOR, NEW YORK |
/s/ Jeffrey Meckler |
13 Feb 2026 |
0001506916 |
Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)
| Type |
Sym |
Class |
Transaction |
Value $ |
Shares |
Change % |
* Price $ |
Shares After |
Date |
Underlying Class |
Amount |
Exercise Price |
Ownership |
Footnotes |
| transaction |
INDP |
Warrants (right to buy) |
Disposed to Issuer |
|
-3,033 |
-100% |
|
0 |
11 Feb 2026 |
Common Stock |
3,033 |
$47.60 |
Direct |
F1 |
| transaction |
INDP |
Warrants (right to buy) |
Award |
|
+3,033 |
|
|
3,033 |
11 Feb 2026 |
Common Stock |
3,033 |
$1.75 |
Direct |
F1 |
| transaction |
INDP |
Warrants (right to buy) |
Disposed to Issuer |
|
-1,519 |
-100% |
|
0 |
11 Feb 2026 |
Common Stock |
1,519 |
$29.40 |
Direct |
F1 |
| transaction |
INDP |
Warrants (right to buy) |
Award |
|
+1,519 |
|
|
1,519 |
11 Feb 2026 |
Common Stock |
1,519 |
$1.75 |
Direct |
F1 |
| transaction |
INDP |
Warrants (right to buy) |
Disposed to Issuer |
|
-12,136 |
-100% |
|
0 |
11 Feb 2026 |
Common Stock |
12,136 |
$8.30 |
Direct |
F1 |
| transaction |
INDP |
Warrants (right to buy) |
Award |
|
+12,136 |
|
|
12,136 |
11 Feb 2026 |
Common Stock |
12,136 |
$1.75 |
Direct |
F1 |
* An asterisk sign (*) next to the price indicates that the price is likely invalid.
Explanation of Responses:
Remarks:
On June 26, 2025, the Company effected a 1-for-28 reverse stock split (the "Reverse Stock Split") of the Company's common stock. All amounts have been adjusted to give effect to the Reverse Stock Split.